Watson Pharma Private Limited is a wholly owned subsidiary of the Teva Group, world leader in the manufacture of api's and generic pharmaceuticals. Watson Pharma became part of Teva Group with effect from August 2016.
The Site is spread across in 40,000 m2 area with a facility built-up area of 23,835 m2. This Integrated api Manufacturing site has state-of-the-art Infrastructure & Capability to handle complex Chemical reactions supported by integrated utilities and very well-equipped quality control laboratories. The site has two plants to manufacture large commercial products and a multi-purpose manufacturing plant designed to handle small volume and exhibit batches with overall capacity of 60-80 tons annually.
6 years without any reportable injury